Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Baudax Bio, Inc. (BXRX)
Sector: Healthcare; Industry: Biotechnology

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. Its lead product candidate is intravenous form of meloxicam, a non-opioid that has completed Phase III clinical trials for the management of moderate to severe pain; and is in the Phase IIIb clinical trials in colorectal surgery and orthopedic surgery patients to assess opioid consumption, pain intensity, and length of hospital stay with associated pharmacoeconomic parameters. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.

Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-06-07 CHURCHILL WINSTON J Director Buy 25,000 $0.78 $19,509 No
2021-05-14 Casten Richard S Chief Financial Officer Buy 25,000 $0.79 $19,748 No
2021-03-15 Casten Richard S Chief Financial Officer Buy 25,000 $1.41 $35,180 No
2020-11-23 ALTOMARI ALFRED Director Buy 5,000 $1.06 $5,300 No
2020-03-26 CHURCHILL WINSTON J Director Buy 31,500 $2.41 $75,820 No
2020-03-26 Weisman Wayne Director Buy 10,000 $2.29 $22,900 No
2020-03-26 ALTOMARI ALFRED Director Buy 5,000 $2.34 $11,700 No

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.

Insider Smart

Camping World Holdings, Inc (CWH) - Another crash victim, Camping World Holdings, Inc took a deep dive from $16 to $4, several insiders bought around $6. With insiders on your side, this would be an easy add and hold to get your cost under $6. A 300% gain because stock is about to breach $25 in the coming weeks.